Abiraterone Acetate in Combination With Tildrakizumab
Condition: Metastatic Castration Resistant Prostate Cancer Interventions: Drug: Abiraterone Acetate; Drug: Tildrakizumab Sponsors: Institute of Cancer Research, United Kingdom; Sun Pharma Global FZE Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials